NEW

Healthmark Offers New Vendor Credentialing Program

Healthmark Industries’ clinical affairs team has announced the creation of 13 training programs that will be offered for vendors and manufacturer representatives to satisfy vendor credentialing requirements.

Interim Life in the Age of COVID

An interim director of surgical services is familiar with unpredictability. In a new assignment, the needs of the OR, often disparate, compete for their attention. Prioritizing what to execute first is a delicate balancing act.

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical Inc. (formerly TransEnterix Inc.) has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. A news release states that Asensus Surgical's technology...

Staying Positive During the Pandemic

The good news for patients in need of outpatient surgery is that, across the country, health care providers and policymakers have recognized that elective surgery is not the same thing as optional surgery and are allowing ASCs to remain open to provide this care.

Mölnlycke acquires patent for smart solutions to detect infection in wounds

The Swedish medical solutions company, Mölnlycke, is acquiring a patent from Innovation Skåne, that will help detect infections in wounds. Once developed, the patent will play a major role in reducing the unnecessary use of antibiotics in wound care.

The incidence of infection in hard-to-heal chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is high – and one in 20 patients undergoing surgery will develop a surgical site infection [1]. However, infected wounds are costly, difficult to manage and hard to detect. In many cases, expensive antimicrobials are used prophylactically to prevent infections or to treat them once they have been established.

Mölnlycke has agreed to acquire the patent from Swedish regional innovation company, Innovation Skåne. This technology can detect infections and alert caregivers that the wound needs attention. It will help to minimise the prophylactic use of antibiotics and reduce the risk of complications related to infections.

Barry McBride, Executive Vice President R&D said: “Antimicrobial resistance is an increasingly significant threat to public health worldwide. This exciting new technology will help reduce the incidence of serious infection and minimise the unnecessary use of antibiotics.”

Joakim Nelson, CEO of Innovation Skåne, said: “This is an example of innovations originating from employees in Region Skåne and demands in their daily work. We share Mölnlycke’s goal of driving innovative improvements in healthcare and we are delighted Mölnlycke will be able to use this patent to help tackle a serious public healthcare issue.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X